UPDATE : Thursday, August 6, 2020
Greater Seoul remains jittery over sporadic, silent spreads
Korea’s new Covid-19 cases have remained between 30 and 40 over the past fe...
by Shim Hyun-tai  |  2020-06-04 14:38
MedPacto to test Vactosertib for treating NSCLC
MedPacto has applied for phase 2 clinical trials concerning the combined us...
by Lee Han-soo  |  2020-06-04 12:43
Korea to spend ₩1 trillion on fight against infectious diseases
The Ministry of Health and Welfare said Wednesday that 1.05 trillion won ($...
by Shim Hyun-tai  |  2020-06-03 18:18
Dupixent to provide new treatment options for asthma patients
Sanofi-Aventis Korea said Wednesday it would enter the local asthma drug ma...
by Lee Han-soo  |  2020-06-03 17:54
[ASCO 2020 ④] MedPacto's Vactosertib combo treatment for desmoid tumors proved safe
MedPacto said the combination of its small molecule TGF-B inhibitor, Vactos...
by Shim Hyun-tai  |  2020-06-03 17:20
New plasma-based method found to treat refractory blood cancer
A new method has been found to treat chronic myelogenous leukemia, a type o...
by Lee Han-soo  |  2020-06-03 16:29
Seoul OKs special import of remdesivir as Covid-19 treatment
The Ministry of Food and Drug Safety said it has granted emergency approval...
by Kim Yun-mi  |  2020-06-03 16:05
Treating helicobacter bacteria after gastric cancer surgery lifts survival rate
A research team at Seoul National University Bundang Hospital has discovere...
by Lee Han-soo  |  2020-06-03 16:05
Korea confirms Covid-19 candidate drug’s effect through weasels
A locally developed antibody treatment candidate to fight Covid-19 showed a...
by Kwak Sung-sun  |  2020-06-03 16:05
‘KOEDC to broaden drug accessibility for patients with rare diseases’
“As the head of Korea Orphan and Essential Drug Center putting patients fir...
by Kim Yun-mi  |  2020-06-03 12:37
Unrelenting church-linked infections raise worries about new viral wave
Korea’s new Covid-19 cases rebounded on Wednesday, as cluster infections li...
by Shim Hyun-tai  |  2020-06-03 12:34
‘Mental, behavioral disorders’ social costs larger than their medical expense’
Indirect social and economic costs caused by psychological and behavioral d...
by Shim Hyun-tai  |  2020-06-02 18:28
[ASCO 2020 ③] Genexine’s combo therapy for breast cancer proves safety
Genexine said that the combination therapy of its Hyleukin-7 and MSD’s Keyt...
by Shim Hyun-tai  |  2020-06-02 17:14
CDK 4/6 inhibitor market to heat up on insurance benefits
Hormone receptor (HR) positive, human epidermal growth factor receptor 2 (H...
by Lee Han-soo  |  2020-06-02 17:13
‘54% of MERS survivors had mental illness even 1 year after recovery’
More than half of the survivors of the Middle East Respiratory Syndrome in ...
by Choi Gwang-seok  |  2020-06-02 15:38
‘Covid-19 heroes? Nurses worry about pay cuts’ 
“Why should doctors and nurses fighting Covid-19 worry about money, too?”Sh...
by Song Soo-youn  |  2020-06-02 15:33
Resurge of church-linked virus cases dims outlook for broader school reopening
Infections originating from smaller churches in the Seoul metro region are ...
by Shim Hyun-tai  |  2020-06-02 14:45
‘Keytruda doubled survival in advanced colon cancer compared to chemo’
MSD’s Keytruda (ingredient: pembrolizumab) extended the progression-free su...
by Kim Yun-mi  |  2020-06-02 11:27
[ASCO 2020 ②] GC confirms safety, efficacy of anti-EGFR monoclonal antibody
GC has come up with optimal interim results for its phase 1b/2a clinical tr...
by Lee Han-soo  |  2020-06-02 11:20
[ASCO 2020 ①] Samsung Bioepis’ anticancer biosimilar shows equal quality to original drug
Samsung Bioepis headquarters in Songdo, Incheon. Samsung Bioepis said tha...
by Lee Han-soo  |  2020-06-01 16:14
Back to Top